ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G. Kemps, Brianna Empringham, Antje Bornemann et al.|Blood|2021Cited by 157
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutationsChristian Koelsche, Andreas von Deimling, Martin Mynarek et al.|Acta Neuropathologica|2018Cited by 143
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’Karin P.S. Langenberg, Patrick Kemmeren, Michael T. Meister et al.|European Journal of Cancer|2022Cited by 61
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma SubgroupsStefan G. van Ravensteijn, Ingrid M.E. Desar, Yvonne M.H. Versleijen‐Jonkers et al.|Cancers|2022Cited by 19
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker AnalysesStefan G. van Ravensteijn, Ingrid M.E. Desar, Jacco J. de Haan et al.|Clinical Cancer Research|2025Cited by 6